Dacarbazine, cisplatin, and interferon-alfa-2b with or without interleukin-2 in metastatic melanoma: a randomized phase III trial (18951) of the European Organisation for Research and Treatment of Cancer Melanoma Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples